Fairvalue-Calculator Fairvalue-Calculator
EN DE

Nightingale Health Oyj (NGHLF) Fair Value & Analysis

Healthcare · US · Market cap $71.8M

Price$1.19
Fair Value$1.11
Upside-6.7%
Quality95/100
Evidence: Low Range $0.7300 – $1.39

Fair value as of: Jun 25, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Nightingale Health Oyj (NGHLF) currently trades at $1.19, while our model-based Fair Value estimate is $1.11 — implying the stock looks roughly 6.7% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Nightingale Health Oyj, a health technology company, offers advanced health check that detects disease risks in Finland, the United Kingdom, rest of Europe, the United States, and internationally. The company's Health Check that detects the risks associated with various common chronic diseases from a single blood sample; and Remote Health Check where health check done remotely. It also offers blood analysis, self collection kits, urine analysis, and biomarkers services. It provides its services to research programs, universities, and healthcare providers. Nightingale Health Oyj was incorporated in 2002 and is headquartered in Helsinki, Finland.

Open the full interactive analysis →

Similar stocks

Veeva Systems Inc (VEEV) -35% Pro Medicus Limited (PME) -86% BrightSpring Health Services, Inc (BTSG) -68% Tempus AI, Inc (TEM) -74% HealthEquity, Inc (HQY) -33% M3, Inc (MTHRY) +2%

Frequently asked questions

Is Nightingale Health Oyj (NGHLF) undervalued?
As of Jun 25, 2026, our model estimates a fair value of $1.11 versus a price of $1.19 — about −7% (overvalued). Model-based estimate, not financial advice.
What is the fair value of NGHLF?
Our 21-model fair value for Nightingale Health Oyj is $1.11 (as of Jun 25, 2026), built from audited fundamentals. The current price is $1.19.
What is the quality score of NGHLF?
Nightingale Health Oyj has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.